Skip to main content
Clinical Trials/NCT04012554
NCT04012554
Unknown
Not Applicable

The Feasibility and Safety of Avoiding Chest Tube Placement After Video-assisted Thoracoscopic Surgery (VATS)of the Lung

Xueying Yang1 site in 1 country100 target enrollmentJune 1, 2019
ConditionsLung Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Diseases
Sponsor
Xueying Yang
Enrollment
100
Locations
1
Primary Endpoint
operation time
Last Updated
6 years ago

Overview

Brief Summary

This is a prospective randomized controlled trial.The main study content is the feasibility and safety of avoiding chest tube placement after Video-Assisted Thoracoscopic Surgery lung disease,participants were randomly divided into experimental group and control group.Avoiding chest tube placement after VATS of the lung in the experimental group.Indwelling thoracic drainage tube after VATS of the lung in the control group.

Detailed Description

This is a prospective randomized controlled trial.The main study content is the feasibility and safety of avoiding chest tube placement after VATS of the lung,divided into experiment group and control group.Communicating with surgeon and patients who met the inclusion criteria,decided whether to enter the experimental group or control group. Experimental group avoid chest tube placement after VATS of the lung and control group indwell thoracic drainage tube after VATS of the lung.By collecting personal information of two groups of patients and the corresponding observation indicators to analyze whether the treatment of avoiding chest tube placement after VATS of the lung is more beneficial than the conventional indwell thoracic drainage tube after VATS of the lung,and it's safe and feasible.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
July 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Xueying Yang
Responsible Party
Sponsor Investigator
Principal Investigator

Xueying Yang

professor

Shengjing Hospital

Eligibility Criteria

Inclusion Criteria

  • 1.Age ranges from 18 to 75 years old,do the examination of chest CT showed pulmonary disease,no invasion of peripheral blood vessels and viscera,no pleural effusion and pericardial effusion.
  • 2.Electrocardiogram, pulmonary function,color doppler ultrasound of the heart,arteries and veins of both lower limbs are normal,no potential infection was confirmed before surgery, no serious organic disease of the heart and lung,and no obvious operation contrain.

Exclusion Criteria

  • 1.The lungs continue to leak air preoperation more than six days. 2.The appearment of the hemothorax,empyema and chylothorax preoperative. 3.The appearment of the preoperative chest X-ray pulmonary atelectasis and pulmonary infection.
  • 4.The lungs leak air appears in the surgery. 5.Patients with severe cardiovascular and cerebrovascular accident after operation were terminated.
  • 6.Impaired lung function (forced expiratory volume in 1 second \[FEV1\]\<60% predicted).

Outcomes

Primary Outcomes

operation time

Time Frame: 1 day

From the beginnning of ansesthesia to the end of anesthesia

hospitalization expenses

Time Frame: 15 days

the total cost of hospitalzation

postoperative complication rate

Time Frame: a month

incidence of postoperative complications such as pneumothorax and hydrohorax

VAS pain scores

Time Frame: 3 days

the VAS pain score was given to patients and the pain scores were recorded at 6h,12h,24h,48h,and 72h postoperatively.The minimum score is 0 and the maximum score is 10.The high values represent a worse outcome.

postoperative extubation time

Time Frame: 1 day

postoperative extubation time

duration of postoperation pain

Time Frame: 10 days

postoperative pain duration

the time of early ambulation after operation

Time Frame: 1 day

the time from the patient's postoperative pushback to the first bedtime

Study Sites (1)

Loading locations...

Similar Trials